Cargando…
Using antifibrinolytics to tackle neuroinflammation
Plasmin is generally known as a promotor of inflammation. Recent advancement suggests that it has a complex role as immunity modulator. Pharmacological inhibition of plasmin production and activity has been proven to improve neurological outcomes in traumatic brain injury and subarachnoid hemorrhage...
Autores principales: | Atsev, Stanimir, Tomov, Nikola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749481/ https://www.ncbi.nlm.nih.gov/pubmed/32594031 http://dx.doi.org/10.4103/1673-5374.284979 |
Ejemplares similares
-
Antifibrinolytics
por: Székely, A, et al.
Publicado: (2014) -
Antifibrinolytics in liver surgery
por: Makwana, Jalpa, et al.
Publicado: (2010) -
Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
por: Pechlivani, Nikoletta, et al.
Publicado: (2021) -
Antifibrinolytic Agents in Traumatic Haemorrhage
por: Coats, Tim, et al.
Publicado: (2005) -
Antifibrinolytic Agents: Aprotinin, and Desmopressin
por: Bajaj, Pramila
Publicado: (2009)